Salta al menu principale di navigazione Salta al contenuto principale Salta al piè di pagina del sito
FrancoAngeli Journals

Saggi

N. 135 (2025)

Soluzioni per ottimizzare l’organizzazione delle campagne antinfluenzali nelle aziende sanitarie

DOI
https://doi.org/10.3280/mesa2025-135oa23141
Inviata
giugno 24, 2026
Pubblicato
2026-10-01

Abstract

L’articolo analizza come le campagne antinfluenzali promuovano il cambiamento organizzativo nelle aziende sanitarie pubbliche italiane, influenzando in modo significativo l’organizzazione interna e le dinamiche relazionali.
L’analisi utilizza tre riferimenti teorici principali: la teoria della contingenza strutturale, per comprendere come le campagne agiscano da stimolo a riorganizzazioni interne; il modello di Kotter, per guidare il cambiamento in modo strutturato; la stakeholder theory, che riconosce il ruolo centrale delle relazioni nel successo delle campagne.
L’articolo ha l’obiettivo di esplorare:
• in che modo le campagne impattino sul funzionamento delle aziende sanitarie;
• il ruolo degli stakeholder nelle dinamiche organizzative e relazionali;
• come le esperienze maturate nel corso delle campagne possano essere capitalizzate.

Riferimenti bibliografici

  1. Adams L.M. (2009). Exploring the Concept of Surge Capacity. OJIN: The Online Journal of Issues in Nursing. DOI: 10.3912/OJIN.Vol14No02PPT03.
  2. Amicizia D., Allegretti S., Grammatico F., Astengo M., Marchini F., Battaglini A., Schenone I., Schiavetti I., Sticchi C., Rebesco B. et al. (2025). Determinants of accepting or rejecting influenza vaccination ‒ Results of a survey among Ligurian pharmacy visitors during the 2023/2024 vaccination campaign. Vaccines, 13(6), 580. DOI: 10.3390/vaccines13060580.
  3. Andrew M. K., Pott H., Staadegaard L., Paget J., Chaves S. S., Ortiz J. R., McCauley J., Bresee J., Nunes M. C., Baumeister E., Raboni S. M., Giamberardino H. I. G., McNeil S. A., Gomez D., Zhang T., Vanhems P., Koul P. A., Coulibaly D., Otieno N. A., Dbaibo G., Guerrero Almeida M. L., Laguna-Torres V. A., Drăgănescu A. C., Burtseva E., Sominina A., Danilenko D., Medić S., Diez-Domingo J., Lina B., & GIHSN Investigators (2023). Age differences in comorbidities, presenting symptoms, and outcomes of influenza illness requiring hospitalization: A worldwide perspective from the Global Influenza Hospital Surveillance Network. Open Forum Infectious Diseases, 10(6), ofad244. DOI: 10.1093/ofid/ofad244.
  4. Ansell C., & Gash A. (2008). Collaborative governance in theory and practice. Journal of Public Administration Research and Theory, 18(4): 543-571. DOI: 10.1093/jopart/mum032.
  5. Appelbaum S. H., Habashy S., Malo J.-L., & Shafiq H. (2012). Back to the future: Revisiting Kotter’s 1996 change model. Journal of Management Development, 31(8): 764-782. DOI: 10.1108/02621711211253231.
  6. Argandoña A. (2011). Stakeholder theory and value creation (IESE Business School Working Paper No. 922). DOI. 10.2139/ssrn.1947317.
  7. Balogun J. (2003), From Blaming the Middle to Harnessing its Potential: Creating Change Intermediaries. British Journal of Management, 14: 69-83. DOI: 10.1111/1467-8551.00266.
  8. Balogun J., & Johnson G. (2004). Organizational Restructuring and Middle Manager Sensemaking. The Academy of Management Journal, 47(4), 523-549. DOI: 10.2307/20159600.
  9. Barbisch D. F., & Koenig K. L. (2006). Understanding surge capacity: essential elements. Academic emergency medicine: official journal of the Society for Academic Emergency Medicine, 13(11): 1098-1102. DOI: 10.1197/j.aem.2006.06.041.
  10. Bonazzi G. (1989). Storia del pensiero organizzativo. Milano: FrancoAngeli.
  11. Bryson J. M. (1988). A strategic planning process for public and non-profit organizations. Long Range Planning, 21(1): 73-81. DOI: 10.1016/0024-6301(88)90061-1.
  12. Bryson J. M. (1995). Strategic planning for public and non-profit organizations (pp. 71-75). Jossey-Bass.
  13. Bryson J.M., & Humphrey H.H. (2003). What To Do When Stakeholders Matter: A Guide to Stakeholder Identification and Analysis Techniques.
  14. Capodici A., Salussolia A., La Fauci G., Di Valerio Z., Montalti M., Odone A., Costantino C., Larson H. J., Leask J., Lenzi J. et al. (2024). Influenza vaccine uptake in Italy ‒ The 2022-2023 seasonal influenza vaccination campaign in Italy: An update from the OBVIOUS project. Vaccines, 12(3), 297. DOI: 10.3390/vaccines12030297.
  15. Carman A. L., Vanderpool R. C., Stradtman L. R., & Edmiston E. A. (2019). A change-management approach to closing care gaps in a federally qualified health center: A rural Kentucky case study. Preventing Chronic Disease, 16, E28. DOI: 10.5888/pcd16.180589.
  16. Carrieri V., Madio L., & Principe F. (2019). Vaccine hesitancy and (fake) news: Quasi-experimental evidence from Italy. Health economics, 28(11): 1377-1382. DOI: 10.1002/hec.3937.
  17. Caserotti M., Gavaruzzi T., Girardi P., Sellaro R., Rubaltelli E., Tasso A., & Lotto L. (2022). People’s perspectives about COVID-19 vaccination certificate: Findings from a representative Italian sample. Vaccines, 40(51): 7406-7414. DOI: 10.1016/j.vaccine.2022.08.016.
  18. Cavicchi C., Romiti A., Vagnoni E., & Del Vecchio M. (2025). Innovation as a robust response to crises in public healthcare organizations: Evidence from Italy. Public Money & Management, 1-12. DOI: 10.1080/09540962.2025.2484589.
  19. Ceccarelli A., Soro G., Reali C., Biguzzi E., Farneti R., Frassineti V., Angelini R., Belloli G. L., Gori D., & Montalti M. (2024). The influence of altitude, urbanization, and local vaccination centers on vaccine uptake within an Italian health district: An analysis of 15,000 individuals eligible for vaccination. Vaccines, 12(8), 875. DOI: 10.3390/vaccines12080875.
  20. Chang CS., Chen SY. & Lan YT. Service quality, trust, and patient satisfaction in interpersonal-based medical service encounters. BMC Health Serv Res, 13, 22. DOI: 10.1186/1472-6963-13-22.
  21. Chen W., & Stoecker C. (2020). Mass media coverage and influenza vaccine uptake. Vaccines, 38(2): 271-277. DOI: 10.1016/j.vaccine.2019.10.019.
  22. Crocetti E., Arniani S., Bordoni F., Maciocco G., Zappa M., & Buiatti E. (2001). Effectiveness of influenza vaccination in the elderly in a community in Italy. European journal of epidemiology, 17(2): 163-168. DOI: 10.1023/a:1017978420601.
  23. Dai T., Cho S.-H., & Zhang F. (2016). Contracting for on-time delivery in the U.S. influenza vaccine supply chain. Manufacturing & Service Operations Management, 18(3): 332-346. DOI: 10.1287/msom.2015.0574.
  24. de Belvis A., Meregaglia M., Morsella A., Adduci A., Perilli A., Cascini F., Solipaca A., Fattore G., Ricciardi W., Maresso A., & Scarpetti G. (2022). Italy: Health System Review. Health systems in transition, 24(4): 1-236.
  25. de Fougerolles T.R., Baïssas T., Perquier G. et al. (2024). Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives. BMC Public Health, 24, 1222. DOI: 10.1186/s12889-024-18694-5.
  26. de Kok K., van der Scheer W., Ketelaars C. et al. (2023). Organizational attributes that contribute to the learning & improvement capabilities of healthcare organizations: a scoping review. BMC Health Serv Res, 23, 585. DOI: 10.1186/s12913-023-09562-w.
  27. de Koning R., Gonzalez Utrilla M., Spanaus E., Moore M., & Lomazzi M. (2024). Strategies used to improve vaccine uptake among healthcare providers: A systematic review. Vaccines, X(19), 100519. DOI: 10.1016/j.jvacx.2024.100519.
  28. Domnich A., Lapi F., Orsi A. et al. (2024). Declining number of general practitioners can impair influenza vaccination uptake among Italian older adults: Results from a panel analysis. BMC Health Serv Res, 24, 950. DOI: 10.1186/s12913-024-11443-9.
  29. Dubé E., Gagnon D., & MacDonald N. E. (2015). Strategies intended to address vaccine hesitancy: Review of published reviews. Vaccines, 33(34): 4191-4203. DOI: 10.1016/j.vaccine.2015.04.041.
  30. Eilers R., Krabbe P. F. M., & de Melker H. E. (2014). Factors affecting the uptake of vaccination by the elderly in Western society. Preventive Medicine, 69: 224-234. DOI: 10.1016/j.ypmed.2014.10.017.
  31. Fattore G., Pongiglione B. & Vezzosi L. (2024). Excess hospitalizations and in-hospital mortality associated with seasonal influenza in Italy: a 11-year retrospective study. BMC Infect Dis, 24, 227. DOI: 10.1186/s12879-024-09071-z.
  32. Fotiadis K., Dadouli K., Avakian I., Bogogiannidou Z., Mouchtouri V. A., Gogosis K., Speletas M., Koureas M., Lagoudaki E., Kokkini S. et al. (2021). Factors associated with healthcare workers’ (HCWs) acceptance of COVID-19 vaccinations and indications of a role model towards population vaccinations from a cross-sectional survey in Greece, May 2021. International Journal of Environmental Research and Public Health, 18(19), 10558. DOI: 10.3390/ijerph18191055.
  33. Freeman R. E. (1984). Strategic management: A stakeholder approach. Pitman Publishing Inc.
  34. Freeman R. E., & McVea J. (2001). A stakeholder approach to strategic management. Social Science Research Network. DOI: 10.2139/ssrn.263511.
  35. Frutos A. M., Tenforde M. W., Sundaresan D., Naleway A. L., Irving S. A., DeSilva M. B., Kharbanda A. B., Ong T. C., Rao S., Zheng K., Gohil S. K., Ball S. W., Fink R. V., Reed C., Garg S., & Bozio C. H. (2025). Influenza-associated hospitalization rates by underlying conditions, 2016-17 to 2019-20: A retrospective cohort study. The Journal of infectious diseases, jiaf164. Advance online publication. DOI: 10.1093/infdis/jiaf164.
  36. Gai Y., & Gu N. Y. (2014). Relationship between local family physician supply and influenza vaccination after controlling for individual and neighborhood effects. American journal of infection control, 42(5): 500-505. DOI. 10.1016/j.ajic.2013.12.006.
  37. Galbraith J. (1973). Designing Complex Organizations. Addison-Wesley, Boston.
  38. González-Block M. Á., Díaz Portillo S. P., Arroyo Laguna J., & et al. (2022). Barriers and facilitators to influenza vaccination observed by officers of national immunization programs in South America countries with contrasting coverage rates. Cadernos de Saúde Pública, 38(3), e00045721. DOI: 10.1590/0102-311X00045721.
  39. Gonzalez-Chica D., Frank O., Edwards J., Hoon E., de Oliveira Bernardo C., Knieriemen A., & Stocks N. (2024). Effectiveness of patient reminders on influenza vaccination coverage among adults with chronic conditions: A feasibility study in Australian general practices. Preventive Medicine, 184, 107983. DOI: 10.1016/j.ypmed.2024.107983.
  40. Grilli R., Ramsay C., & Minozzi S. (2002). Mass media interventions: Effects on health services utilisation. Cochrane Database of Systematic Reviews, (1), CD000389. DOI: 10.1002/14651858.CD000389.
  41. Grossi A., Bella A., Caraglia A., Maraglino F., & Rizzo C. (2021). La copertura vaccinale antinfluenzale in Italia: andamento nella popolazione generale e ultrasessantaquattrenne, dal 1999-2000 al 2019-2020. Bollettino Epidemiologico Nazionale, 2(1): 1-7. DOI: 10.53225/BEN_008.
  42. Gualano M. R., Santoro P. E., Borrelli I., Rossi M. F., Amantea C., Tumminello A., Daniele A., Beccia F., & Moscato U. (2022). Employee participation in workplace vaccination campaigns: A systematic review and meta-analysis. Vaccines, 10(11), 1898. DOI: 10.3390/vaccines10111898.
  43. Gutterman A. (2023). Designing the organizational structure. DOI: 10.2139/ssrn.4548234.
  44. Hanly M., Churches T., Fitzgerald O. et al. (2022). Modelling vaccination capacity at mass vaccination hubs and general practice clinics: a simulation study. BMC Health Serv Res, 22, 1059. DOI: 10.1186/s12913-022-08447-8.
  45. Harrison J. S., & St. John C. H. (1996). Managing and partnering with external stakeholders. The Academy of Management Executive, 10(2): 46-60. DOI: 10.5465/AME.1996.9606161554.
  46. Harrison R., Fischer S., Walpola R. L., Chauhan A., Babalola T., Mears S., & Le-Dao H. (2021). Where Do Models for Change Management, Improvement and Implementation Meet? A Systematic Review of the Applications of Change Management Models in Healthcare. Journal of healthcare leadership, 13: 85-108. DOI. 10.2147/JHL.S289176.
  47. Hazazi A. Y., Al Ahmadi A. M., Al Enizy F. F., Al Sharif M. S., Al Sobhi A. A., Al Mutairi M. H., & Al Anazi M. S. (2023). Managing Seasonal Vaccination Campaigns: A Comprehensive Critical Review. International Journal of Development Research, 13(11): 28734-28737. DOI: 10.37118/ijdr.28734.11.2023.
  48. Hu Y., Wang Y., Cao R., Hu C., Feng B., Li J., Ding X., Ma J., Li H., Wang P., Xu Y., Xu D., Pei J., Zhu X., Chen J., Liang K., Peng Z., Kashani K., Hu B., & Yuan Y. (2025). Kotter’s 8-step change model to improve hand hygiene compliance in intensive care unit: A 41-month prospective longitudinal quality improvement study. Intensive and Critical Care Nursing, 87, 103877. DOI: 10.1016/j.iccn.2024.103877.ù
  49. Huy Q. N. (2002). Emotional Balancing of Organizational Continuity and Radical Change: The Contribution of Middle Managers. Administrative Science Quarterly, 47(1): 31-69. DOI: 10.2307/3094890.
  50. Iserson K. V. (2020). Augmenting the Disaster Healthcare Workforce. The western journal of emergency medicine, 21(3): 490-496. DOI: 10.5811/westjem.2020.4.47553.
  51. Kelen G.D. & McCarthy M.L. (2006), The Science of Surge. Academic Emergency Medicine, 13: 1089-1094. DOI: 10.1197/j.aem.2006.07.016.
  52. Kotter J.P. (1996) Leading Change. Harvard Business School Press, Boston.
  53. Kumar M., & Vinati V. (2024). Stakeholder Engagement and Collaboration in Health Policy Implementation: Lessons Learned. South Eastern European Journal of Public Health, 104-119. DOI: 10.70135/seejph.vi.491.
  54. Levi M., Bonanni P., Biffino M., Conversano M., Corongiu M., Morato P., & Maio T. (2018). Influenza vaccination 2014-2015: Results of a survey conducted among general practitioners in Italy. Human vaccines & immunotherapeutics, 14(6): 1342-1350. DOI: 10.1080/21645515.2018.1430543.
  55. Lin Q., Zhao Q., & Lev B. (2021). Influenza vaccine supply chain coordination under uncertain supply and demand. European Journal of Operational Research. DOI: 10.1016/j.ejor.2021.05.025.
  56. Liu Y., & Yin J. (2020). Stakeholder relationships and organizational resilience. Management and Organization Review, 16(5): 986-990. DOI: 10.1017/mor.2020.58.
  57. Lowe G. (2012). How employee engagement matters for hospital performance. Healthcare quarterly (Toronto, Ont.), 15(2): 29-39. DOI: 10.12927/hcq.2012.22915.
  58. Ly L. T., Maggi F. M., Montali M., Rinderle-Ma S., & van der Aalst W. M. (2015). Compliance monitoring in business processes: Functionalities, application, and tool-support. Information systems, 54: 209-234. DOI: 10.1016/j.is.2015.02.007.
  59. Manzoli L., Gabutti G., Siliquini R., Flacco M. E., Villari P., & Ricciardi W. (2018). Association between vaccination coverage decline and influenza incidence rise among Italian elderly. European journal of public health, 28(4): 740-742. DOI: 10.1093/eurpub/cky053.
  60. Martin D. R., Brauner M. E., & Plouffe J. F. (2008). Influenza and pneumococcal vaccinations in the emergency department. Emergency medicine clinics of North America, 26(2): 549-xi. DOI: 10.1016/j.emc.2008.02.004.
  61. Mazzochi K., Aldridge E., Hackett L., Miller J., Leach D., Lukins J., Jordan P., & Buntine P. (2023). Medical student deployment to a single metropolitan hospital during the COVID-19 pandemic: A mixed methods analysis. Emergency medicine Australasia: EMA, 35(6): 960-967. DOI: 10.1111/1742-6723.14273.
  62. McKinley C. J., Olivier E., & Ward J. K. (2023). The influence of social media and institutional trust on vaccine hesitancy in France: Examining direct and mediating processes. Vaccines, 11(8), 1319. DOI: 10.3390/vaccines11081319.
  63. Mitchell R. K., Agle B. R., & Wood D. J. (1997). Toward a Theory of Stakeholder Identification and Salience: Defining the Principle of Who and What Really Counts. The Academy of Management Review, 22(4): 853-886. DOI: 10.2307/259247.
  64. Mounier-Jack S., Bell S., Chantler T., Edwards A., Yarwood J., Gilbert D., & Paterson P. (2020). Organisational factors affecting performance in delivering influenza vaccination to staff in NHS Acute Hospital Trusts in England: A qualitative study. Vaccines, 38(15): 3079-3085. DOI: 10.1016/j.vaccine.2020.02.077.
  65. Nayak J., Hoy G., & Gordon A. (2021). Influenza in Children. Cold Spring Harbor perspectives in medicine, 11(1), a038430. DOI: 10.1101/cshperspect.a038430.
  66. Nicholls N., Pleace M., & Yitbarek E. (2024). Trust in government, social media and willingness to vaccinate. Social Science & Medicine, 360, 117302. DOI: 10.1016/j.socscimed.2024.117302.
  67. Nutt P. C. (2002). Why decisions fail: Avoiding the blunders and traps that lead to debacles. San Francisco, CA: Berrett-Koehler Publishers.
  68. Panatto D., Amicizia D., Arata L., Lai P. L., & Gasparini R. (2018). A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation. Human Vaccines & Immunotherapeutics, 14(4): 969-977. DOI: 10.1080/21645515.2017.1407483.
  69. Parrish C., Phares C. A, Fredrickson T., Lynch J. B., Whiteside L. K., & Duber H. C. (2022). Evaluation of an Emergency Department Influenza Vaccination Program: Uptake Factors and Opportunities. Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health, 23(5). DOI: 10.5811/westjem.2022.5.55227.
  70. Parsons T. (1951). The social system. Free Press.
  71. Pascucci D., Lontano A., Marziali E., Vetrugno G., Moscato U., Vaccination Team of Hospital Hygiene Unit, Laurenti, P., & Group authorship (2025). Human Vaccines & Immunotherapeutics, 21(1), 2493027. DOI: 10.1080/21645515.2025.2493027.
  72. Pennisi F., Mastrangelo M., De Ponti E., Cuciniello R., Mandelli A., Vaia F., & Signorelli C. (2024). The role of pharmacies in the implementation of vaccination coverage in Italy. Insights from the preliminary data of the Lombardy Region. Annali di igiene: medicina preventiva e di comunità, 36(3): 363-369. DOI: 10.7416/ai.2024.2611.
  73. Perrone P. M., Scarioni S., Astorri E., Marrocu C., Tiwana N., Letzgus M., Borriello C., & Castaldi S. (2024). Vaccination open day: A cross-sectional study on the 2023 experience in Lombardy Region, Italy. International Journal of Environmental Research and Public Health, 21, 685. DOI. 10.3390/ijerph21060685.
  74. Poscia A., Paolorossi G., Collamati A., Costantino C., Fiacchini D., Angelini C., Bernabei R., Cimini D., Icardi G., Siddu A., Silenzi A., Spadea A., & Vetrano D. L. (2024). Enhancing routine immunization efforts for older adults and frail individuals: Good practices during the SARS-CoV-2 pandemic in Italy. Human vaccines & immunotherapeutics, 20(1), 2330152. DOI: 10.1080/21645515.2024.2330152.
  75. Prati G., Pietrantoni L., & Zani B. (2011). A social-cognitive model of pandemic influenza H1N1 risk perception and recommended behaviors in Italy. Risk analysis: an official publication of the Society for Risk Analysis, 31(4): 645-656. DOI: 10.1111/j.1539-6924.2010.01529.x.
  76. Rizzo C., Bella A., Viboud C., Simonsen L., Miller M. A., Rota M. C., Salmaso S., & Ciofi degli Atti M. L. (2007). Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerging infectious diseases, 13(5): 694-699. DOI: 10.3201/eid1305.061309.
  77. Sañudo Y., Akoglu C., Rietjens J. A. C., Snelders D., Stiggelbout A. M., & Sierra-Pérez J. (2025). The implementation of design methodologies for supporting shared decision making in healthcare services: A systematic review. Patient Education and Counseling, 131, 108551. DOI: 10.1016/j.pec.2024.108551.
  78. Scott T., Mannion R., Davies H. T., & Marshall M. N. (2003). Implementing culture change in health care: theory and practice. International journal for quality in health care: journal of the International Society for Quality in Health Care, 15(2): 111-118. DOI: 10.1093/intqhc/mzg021.
  79. Shukla S., Fressin F., Un M., Coetzer H., & Chaguturu S. K. (2022). Optimizing vaccine distribution via mobile clinics: A case study on COVID-19 vaccine distribution to long-term care facilities. Vaccines, 40(5): 734-741. DOI: 10.1016/j.vaccine.2021.12.049.
  80. Signorelli C., Odone A., Conversano M., & Bonanni P. (2015). Deaths after Fluad flu vaccine and the epidemic of panic in Italy. BMJ (Clinical research ed.), 350, h116. DOI: 10.1136/bmj.h116.
  81. Signorelli C., Pennisi F., D’Amelio A. C., Conversano M., Cinquetti S., Blandi L., & Rezza G. (2024). Vaccinating in Different Settings: Best Practices from Italian Regions. Vaccines, 13(1), 16. DOI: 10.3390/vaccines13010016.
  82. Singleton G., Dowrick A., Manby L., Fillmore H., Syverson A., Lewis-Jackson S., Uddin I., Sumray K., Bautista-González E., Johnson G. and Vindrola-Padros C. (2022). UK Healthcare Workers’ Experiences of Major System Change in Elective Surgery During the COVID-19 Pandemic: Reflections on Rapid Service Adaptation. International Journal of Health Policy and Management, 11(10): 2072-2082. DOI: 10.34172/ijhpm.2021.101.
  83. Su Z., Cheshmehzangi A., McDonnell D., da Veiga C. P., & Xiang Y. T. (2022). Mind the “vaccine fatigue”. Frontiers in Immunology, 13, 839433. DOI: 10.3389/fimmu.2022.839433.
  84. Sun Z. (2025). Determining human resource management key indicators and their impact on organizational performance using deep reinforcement learning. Sci Rep, 15, 5690. DOI. 10.1038/s41598-025-86910-2.
  85. Szeto K., Davis A., Arnold J., Gwilt I., Forrest A., Heyne I., Hewitt A., Diestel-Feddersen P., Edwards D., Singh B., & Maher C. (2025). Stepping toward implementation using codesign: Development of hospital protocols and resources for using wearable activity trackers in a hospital service. Frontiers in Digital Health, 7, 1520991. DOI: 10.3389/fdgth.2025.1520991.
  86. Thompson J. M. (2010). Understanding and managing organizational change: implications for public health management. Journal of public health management and practice: JPHMP, 16(2): 167-173. DOI: 10.1097/PHH.0b013e3181c8cb51.
  87. Thompson W. W., Weintraub E., Dhankhar P., Cheng P. Y., Brammer L., Meltzer M. I., Bresee J. S., & Shay D. K. (2009). Estimates of US influenza-associated deaths made using four different methods. Influenza and other respiratory viruses, 3(1): 37-49. DOI: 10.1111/j.1750-2659.2009.00073.x.
  88. Varga A.I., Spehar I., Veggeland F. et al. (2025). Factors influencing trust among colleagues in hospital settings: a systematic review. BMC Health Serv Res, 25, 16. DOI: 10.1186/s12913-024-12159-6.
  89. Vargas C., Whelan J., Brimblecombe J., & Allender S. (2022). Co-creation, co-design, co-production for public health ‒ a perspective on definition and distinctions. Public health research & practice, 32(2), 3222211. DOI: 10.17061/phrp3222211.
  90. Velasco N., Herrera A., Trujillo-Diaz J. et al. (2024). Design of logistics indicators for monitoring the COVID-19 vaccination process in Colombia. BMC Health Serv Res, 24, 1397. DOI. 10.1186/s12913-024-11843-x.
  91. Walji H. D., Martin E., Brookes T., Ellis S. A., Kolokotroni M., Hernandez L., & Martin-Ucar A. (2024). Using an organizational change model to improve lung cancer surgery services over five years. Journal of thoracic disease, 16(8): 5042-5049. DOI: 10.21037/jtd-23-1537.
  92. Wang M., & Jie F. (2019). Managing supply chain uncertainty and risk in the pharmaceutical industry. Health Services Management Research, 33(3): 156-164. DOI: 10.1177/0951484819845305.
  93. Wang X., Pan J., Liu Z., & Wang W. (2022). Optimization of Vaccination Clinics to Improve Staffing Decisions for COVID-19: A Time-Motion Study. Vaccines, 10(12), 2045. DOI: 10.3390/vaccines10122045.
  94. Watson S. K., Rudge J. W., & Coker R. (2013). Health systems’ “surge capacity”: state of the art and priorities for future research. The Milbank quarterly, 91(1): 78-122. DOI: 10.1111/milq.12003.
  95. Wee K. Z., & Lai A. Y. (2022). Work Engagement and Patient Quality of Care: A Meta-Analysis and Systematic Review. Medical care research and review: MCRR, 79(3): 345-358. DOI: 10.1177/10775587211030388.
  96. Wheeler S. G., Beste L. A., Overland M. K., & Wander P. L. (2025). Interventions in primary care to increase uptake of adult vaccines: a systematic review. Journal of Public Health, 47(2): 222-231. DOI: 10.1093/pubmed/fdaf008.
  97. Whitehead H. S., French C. E., Caldwell D. M., Letley L., & Mounier-Jack S. (2023). A systematic review of communication interventions for countering vaccine misinformation. Vaccines, 41(5): 1018-1034. DOI: 10.1016/j.vaccine.2022.12.059.
  98. Xie Y. J., Liao X., Lin M., Yang L., Cheung K., Zhang Q., Li Y., Hao C., Wang H. H., Gao Y., Zhang D., Molassiotis A., Siu G. K. H., & Leung A. Y. M. (2024). Community Engagement in Vaccination Promotion: Systematic Review and Meta-Analysis. JMIR public health and surveillance, 10, e49695. DOI: 10.2196/49695.
  99. Xu X., Rodgers M. D., & Guo W. (G.). (2021). A hub-and-spoke design for ultra-cold COVID-19 vaccine distribution. Vaccines, 39(41): 6127-6136. DOI: 10.1016/j.vaccine.2021.08.069.
  100. Yoo B. K., Holland M. L., Bhattacharya J., Phelps C. E., & Szilagyi, P. G. (2010). Effects of mass media coverage on timing and annual receipt of influenza vaccination among Medicare elderly. Health services research, 45(5 Pt 1): 1287-1309. DOI: 10.1111/j.1475-6773.2010.01127.x.
  101. Zhao P., Yoo I., Lavoie J., Lavoie B. J., & Simoes E. (2017). Web-Based Medical Appointment Systems: A Systematic Review. Journal of medical Internet research, 19(4), e134. DOI: 10.2196/jmir.6747.
  102. Sitografia
  103. Congressional Research Service (2004), Influenza Vaccine Shortages and Implications, CRS Report for Congress, Order Code RL32655, https://www.everycrsreport.com/reports/RL32655.html (consultato il 01/08/2025).
  104. European Observatory on Health Systems and Policies (2024). Challenges for the Italian National Health Service in 2024: How to plan the future health workforce. https://eurohealthobservatory.who.int/monitors/health-systems-monitor/analyses/hspm/italy-2023/challenges-for-the-italian-national-health-service-in-2024.-how-to-plan-the-future-health-workforce (consultato il 01/08/2025).
  105. Istituto Superiore della Sanità – Coperture della vaccinazione antinfluenzale in Italia https://www.epicentro.iss.it/influenza/coperture-vaccinali (consultato il 01/08/2025).
  106. Organizzazione Mondiale della Sanità (2013). Global Vaccine Action Plan 2011-2020. https://www.who.int/immunization/global_vaccine_
  107. action_plan/GVAP_doc_2011_2020/en/ (consultato il 01/08/2025).
  108. Normativa
  109. Decreto Legge n. 105 del 23 luglio 2021, convertito con Legge n. 126 del 16 settembre 2021.
  110. Ministero della Salute – Prevenzione e controllo dell’influenza: raccomandazioni per la stagione 2024-2025.
  111. Piano Nazionale Prevenzione Vaccinale (PNPV) 2023-2025.
  112. Piano Nazionale Vaccini 1999-2000.